Sands Capital Alternatives, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$421.2M
Q ending 2026-03-31
Prior quarter
$518.5M
Q ending 2025-12-31
Change
-18.8% QoQ · +3.0% YoY
Positions
21
reported holdings

Largest positions

All 21 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Nu Hldgs LtdShares$93.9M6.5M
Klaviyo IncKVYOShares$71.0M3.6M
Spyglass Pharma IncSGPShares$64.8M2.5M
Beta Bionics IncBBNXShares$37.2M3.7M
Inhibikase Therapeutics IncIKTShares$21.9M13.0M
Coupang IncCPNGShares$19.1M1.0M
Samsara IncIOTShares$17.8M560K
Doordash IncDASHShares$16.7M111K
Bioage Labs IncBIOAShares$13.8M786K
10X Genomics IncTXGShares$10.2M482K
Datadog IncDDOGShares$10.1M86K
Acumen Pharmaceuticals IncABOSShares$8.8M3.7M
Toast IncTOSTShares$8.0M302K
Tarsus Pharmaceuticals IncTARSShares$6.0M85K
Servicetitan IncTTANShares$5.7M90K
Monday Com LtdShares$4.7M68K
Taysha Gene Therapies IncTSHAShares$3.2M725K
Snowflake IncSNOWShares$3.1M20K
Acrivon Therapeutics IncACRVShares$3.0M2.1M
Candel Therapeutics IncCADLShares$2.0M406K
Figma IncFIGShares$387K18K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.